Accelrys Biological Registration: Mastering Biological R&D at Its Roots
White Paper Nov 25, 2010
This IDC Health Insights Perspective highlights a new product solution that promises to more effectively register, track, and manage promising biologics, resulting in more efficient biological product development and more systematic intellectual property management and protection. Accelrys' new Biological Registration system is the next step in the extension of its Accord chemical registration capabilities to biological entity registration. With the expanded product portfolio from its proposed merger with Symyx Technologies, Accelrys becomes the dominant industry leader for chemical and biological registration solutions, taking chemical and biologic entity management to a new level.
Related White Papers
23rd World Congress on Pediatrics, Neonatology & Primary Care
Nov 22 - Nov 23, 2019